Terms: = Liver cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Treatment
937 results:
1. Activation of the MEK/erk Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract] [Full Text] [Related]
2. CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcinoma.
Cheng K; Zhou Z; Chen Q; Chen Z; Cai Y; Cai H; Wu S; Gao P; Cai Y; Zhou J; Wang X; Wu Z; Peng B
Sci Rep; 2024 Apr; 14(1):8389. PubMed ID: 38600093
[TBL] [Abstract] [Full Text] [Related]
3. Integrated network toxicology, molecular docking, and in vivo experiments to elucidate molecular mechanism of aflatoxin B1 hepatotoxicity.
Ge B; Yan K; Sang R; Wang W; Liu X; Yu M; Liu X; Qiu Q; Zhang X
Ecotoxicol Environ Saf; 2024 Apr; 275():116278. PubMed ID: 38564860
[TBL] [Abstract] [Full Text] [Related]
4. Investigation of prunetrin induced G2/M cell cycle arrest and apoptosis via Akt/mTOR/MAPK pathways in hepatocellular carcinoma cells.
Abusaliya A; Bhosale PB; Kim HH; Park MY; Jeong SH; Lee S; Kim GS
Biomed Pharmacother; 2024 May; 174():116483. PubMed ID: 38552440
[TBL] [Abstract] [Full Text] [Related]
5. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
6. Exosomal IGFBP2 derived from highly metastatic promotes hepatocellular carcinoma metastasis by inducing epithelial mesenchymal transition.
Zheng Y; Li W; Huang Y; Cheng H
Gene; 2024 Jun; 913():148374. PubMed ID: 38490505
[TBL] [Abstract] [Full Text] [Related]
7. Icaritin activates p53 and inhibits aerobic glycolysis in liver cancer cells.
Zhou X; Wu D; Mi T; Li R; Guo T; Li W
Chem Biol Interact; 2024 Apr; 392():110926. PubMed ID: 38431053
[TBL] [Abstract] [Full Text] [Related]
8. Role of Wisteria floribunda agglutinin binding glycans in carcinogenesis and metastasis of cholangiocarcinoma.
Phuyathip W; Putthisen S; Panawan O; Ma-In P; Teeravirote K; Sintusen P; Udomkitkosol S; Detarya M; Luang S; Mahalapbutr P; Sato T; Kuno A; Chuangchaiya S; Silsirivanit A
Histochem Cell Biol; 2024 May; 161(5):423-434. PubMed ID: 38393396
[TBL] [Abstract] [Full Text] [Related]
9. l-Methionine potentiates anticancer activity of Sorafenib by epigenetically altering DUSP3/erk pathway in hepatocellular carcinoma.
Pal S; Kabeer SW; Sharma S; Tikoo K
J Biochem Mol Toxicol; 2024 Mar; 38(3):e23663. PubMed ID: 38367245
[TBL] [Abstract] [Full Text] [Related]
10. Dipsacus Asperoides-Derived Exosomes-Like Nanoparticles Inhibit the Progression of Osteosarcoma via Activating p38/JNK Signaling Pathway.
Lu J; Chen J; Ye J; Shi Z; Gao X; Chen P; Chang Y; Lin H; Li P
Int J Nanomedicine; 2024; 19():1097-1108. PubMed ID: 38327597
[TBL] [Abstract] [Full Text] [Related]
11. PTBP1 promotes the progression of hepatocellular carcinoma by enhancing the oncogenic splicing switch of FGFR2.
Yu-Ying C; Qian Z; Meng-Hui G; Lan F; Peng-Bo C; Gang-Qiao Z
Yi Chuan; 2024 Jan; 46(1):46-62. PubMed ID: 38230456
[TBL] [Abstract] [Full Text] [Related]
12. A highly oxidized germacranolide from elephantopus tomentosus inhibits the growth of hepatocellular carcinoma cells by targeting EGFR in vitro and in vivo.
Li Q; Niu JQ; Jia JH; Xu W; Bai M; Yao GD; Song SJ
Bioorg Chem; 2024 Feb; 143():107007. PubMed ID: 38039928
[TBL] [Abstract] [Full Text] [Related]
13. SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma.
Man KF; Zhou L; Yu H; Lam KH; Cheng W; Yu J; Lee TK; Yun JP; Guan XY; Liu M; Ma S
Nat Commun; 2023 Nov; 14(1):7863. PubMed ID: 38030644
[TBL] [Abstract] [Full Text] [Related]
14. Transcriptome Profiling of Cardiac Glycoside treatment Reveals EGR1 and Downstream Proteins of MAPK/erk Signaling Pathway in Human Breast cancer Cells.
Pavithran H; Kumavath R; Ghosh P
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958905
[TBL] [Abstract] [Full Text] [Related]
15. Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6.
Li S; Yi Z; Li M; Zhu Z
J Ovarian Res; 2023 Nov; 16(1):212. PubMed ID: 37940982
[TBL] [Abstract] [Full Text] [Related]
16. Hypoxia-induced circ-CDYL-EEF1A2 transcriptional complex drives lung metastasis of cancer stem cells from hepatocellular carcinoma.
Kong R; Wei W; Man Q; Chen L; Jia Y; Zhang H; Liu Z; Cheng K; Mao C; Liu S
Cancer Lett; 2023 Dec; 578():216442. PubMed ID: 37852428
[TBL] [Abstract] [Full Text] [Related]
17. Identification and validation of microtubule depolymerizing agent, CYT997, as a potential drug candidate for hepatocellular carcinoma.
Ahmad F; Ma L; Wei W; Liu Y; Hakim I; Daugherty A; Mujahid S; Radin AA; Chua MS; So S
Liver Int; 2023 Dec; 43(12):2794-2807. PubMed ID: 37833852
[TBL] [Abstract] [Full Text] [Related]
18. Dicalcin suppresses invasion and metastasis of mammalian ovarian cancer cells by regulating the ganglioside-erk1/2 axis.
Miwa N; Hanaue M; Aoba K; Saito R; Takamatsu K
Commun Biol; 2023 Oct; 6(1):1015. PubMed ID: 37803211
[TBL] [Abstract] [Full Text] [Related]
19. A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells.
Kim ES; Kim S; Moon A
Oncol Res; 2023; 31(6):867-875. PubMed ID: 37744269
[TBL] [Abstract] [Full Text] [Related]
20. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract] [Full Text] [Related]
[Next]
